Characterization of the Plasma Metallomic Profile to Acute Exercise in Healthy Men and Women (METALEXO)
NCT ID: NCT05718752
Last Updated: 2024-06-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
38 participants
OBSERVATIONAL
2023-02-07
2024-04-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Muscle Oxidative Capacity Relationship With Muscular Endurance, Fatigue (Multiple Sclerosis).
NCT06083194
Chronic Inflammation and Exercise Responsiveness
NCT02732509
Metabolomics Study on Intensive Care Acquired Muscle Weakness in Polytrauma
NCT03819959
Predicting the Metabolic Biomarkers Associated With Injury in Athletes
NCT06888635
Skeletal Muscle in PASC and ME/CFS Patients
NCT05225688
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Among the different trace element metals, iron is one of the most studied during the last 30 years. Iron is indeed an essential component of hemoglobin and myoglobin allowing an optimal oxygen delivery to organs, especially to skeletal muscle under contraction. Iron also plays a major role in the mitochondrial respiratory chain, as well as in the activity of numerous enzymes. Iron deficiency, especially in plasma iron availability, exerts deleterious consequences on sport performance by promoting iron deficiency anemia. Endurance athletes frequently exhibit iron deficiency (Sim et al., 2019), but the latter could also impact non-athletic populations, especially women (Mota et al., 2019). Disorders in iron metabolism during intense exercise could depend on several factors including hyperhecpidinemia (Roecker et al., 2005). High plasma hepcidin levels indeed contributes to reduction in plasma iron availability classically observed in elite athletes. Moreover, intravascular hemolysis combined to urinary, gastro-intestinal and/or sweat iron lost, could be also observed during prolonged intense exercise (Peeling et al., 2017). All together, these factors can directly impact functional capacities during physical exercise. Interestingly, recent studies support the existence of a strong interaction between the iron metabolism and the other non-ferrous trace elements including among others zinc, copper or cobalt (Loréal et al., 2014; Cavey et al., 2015). During intense physical exercise, the non-ferrous metals could thus directly or indirectly play a role in the modulation of iron import, storage or export in various kind of cells, and so functional capacities.
In this context, the pilot clinical study aims to characterize the plasma metallomic profile in response to an acute intense exercise in healthy men and women. All the volunteers (n=40) will perform 3 visits in the M2S lab: 1) an inclusion visit including anthropometric measures, dietary and physical activity surveys, 2) a second visit to perform the incremental cycling test, 3) a last visit to perform metabolic measures during a 30-min intense exercise (i.e. 90% of mechanical power at anaerobic threshold). Blood samples will be collected before, at the end of this intense exercise, and after 3 hours of recovery to determine in plasma systemic iron metabolism parameters and the concentrations of 29 non-ferrous metals.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy men
no intervention
Maximal incremental exercise test
Gas exchange are measured during all the test on ergocycle until oxygen consumption reach its maximum value
30-min submaximal exercise test
A 30-min submaximal test on ergocycle. Gas exchange are measured during all the test. Blood samples are collected before, at the end of exercise and after 3 hours of recovery
Healthy women
no intervention
Maximal incremental exercise test
Gas exchange are measured during all the test on ergocycle until oxygen consumption reach its maximum value
30-min submaximal exercise test
A 30-min submaximal test on ergocycle. Gas exchange are measured during all the test. Blood samples are collected before, at the end of exercise and after 3 hours of recovery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Maximal incremental exercise test
Gas exchange are measured during all the test on ergocycle until oxygen consumption reach its maximum value
30-min submaximal exercise test
A 30-min submaximal test on ergocycle. Gas exchange are measured during all the test. Blood samples are collected before, at the end of exercise and after 3 hours of recovery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non smoker
* 150-300 min of moderate physical activity or 75-150 min of intensive physical activity per week.
* Written informed consent
Exclusion Criteria
* Cardiovascular risks
* Metabolic diseases (e.g.diabetes)
* Use of non-steroidal anti-inflammatory drugs or aspirin
* Simultaneous participation in another research involving the human person or having recently participated in another research for which the exclusion period has not been completed.
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Rennes 2
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Frédéric Derbré
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frédéric DERBRE, PhD
Role: PRINCIPAL_INVESTIGATOR
Laboratory of Movement, Sport and health Sciences (M2S)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Rennes 2 - Laboratory "Movement, Sport and health Sciences"
Bruz, Brittany Region, France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cleland CL, Hunter RF, Kee F, Cupples ME, Sallis JF, Tully MA. Validity of the global physical activity questionnaire (GPAQ) in assessing levels and change in moderate-vigorous physical activity and sedentary behaviour. BMC Public Health. 2014 Dec 10;14:1255. doi: 10.1186/1471-2458-14-1255.
Peeling P, McKay AKA, Pyne DB, Guelfi KJ, McCormick RH, Laarakkers CM, Swinkels DW, Garvican-Lewis LA, Ross MLR, Sharma AP, Leckey JJ, Burke LM. Factors influencing the post-exercise hepcidin-25 response in elite athletes. Eur J Appl Physiol. 2017 Jun;117(6):1233-1239. doi: 10.1007/s00421-017-3611-3. Epub 2017 Apr 13.
Heffernan SM, Horner K, De Vito G, Conway GE. The Role of Mineral and Trace Element Supplementation in Exercise and Athletic Performance: A Systematic Review. Nutrients. 2019 Mar 24;11(3):696. doi: 10.3390/nu11030696.
Roecker L, Meier-Buttermilch R, Brechtel L, Nemeth E, Ganz T. Iron-regulatory protein hepcidin is increased in female athletes after a marathon. Eur J Appl Physiol. 2005 Dec;95(5-6):569-71. doi: 10.1007/s00421-005-0055-y. Epub 2005 Oct 26.
Sim M, Garvican-Lewis LA, Cox GR, Govus A, McKay AKA, Stellingwerff T, Peeling P. Iron considerations for the athlete: a narrative review. Eur J Appl Physiol. 2019 Jul;119(7):1463-1478. doi: 10.1007/s00421-019-04157-y. Epub 2019 May 4.
Mota JO, Tounian P, Guillou S, Pierre F, Membre JM. Estimation of the Burden of Iron Deficiency Anemia in France from Iron Intake: Methodological Approach. Nutrients. 2019 Sep 1;11(9):2045. doi: 10.3390/nu11092045.
Loreal O, Cavey T, Bardou-Jacquet E, Guggenbuhl P, Ropert M, Brissot P. Iron, hepcidin, and the metal connection. Front Pharmacol. 2014 Jun 4;5:128. doi: 10.3389/fphar.2014.00128. eCollection 2014.
Cavey T, Ropert M, de Tayrac M, Bardou-Jacquet E, Island ML, Leroyer P, Bendavid C, Brissot P, Loreal O. Mouse genetic background impacts both on iron and non-iron metals parameters and on their relationships. Biometals. 2015 Aug;28(4):733-43. doi: 10.1007/s10534-015-9862-8. Epub 2015 Jun 4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A02314-39
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.